Agilon Health (Agilon Health) ROCE % : -73.90% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Agilon Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Agilon Health's annualized ROCE % for the quarter that ended in Dec. 2023 was -73.90%.

Agilon Health ROCE % Historical Data

The historical data trend for Agilon Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health ROCE % Chart

Agilon Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-51.98

-28.33

-53.50

-7.21

-19.50

Agilon Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial												-13.23	5.33	-5.17	-11.64	-73.90

Agilon Health ROCE % Calculation

Agilon Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-187.804	/	( ( (1697.468 - 535.091)	+	(1740.866 - 977.156) )	/ 2 )
	=	-187.804	/	( (1162.377	+	763.71)	/ 2 )
	=	-187.804	/	963.0435
	=	-19.50 %

Agilon Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-643.124	/	( ( (2278.075 - 1301.325)	+	(1740.866 - 977.156) )	/ 2 )
	=	-643.124	/	( ( 976.75	+	763.71 )	/ 2 )
	=	-643.124	/	870.23
	=	-73.90 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Agilon Health (NYSE:AGL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Agilon Health ROCE % Related Terms

Thank you for viewing the detailed overview of Agilon Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilon Health (Agilon Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723

Website

https://www.agilonhealth.com

Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.

Executives

Jeffrey A. Schwaneke	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell	director, officer: CEO & President	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker	officer: Chief Markets Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia	director	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd.	10 percent owner	MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai	officer: Chief Strategy & Dev. Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer	officer: Chief Med. & Quality Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie	director	METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak	officer: Chief Accounting Officer	1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias	officer: Chief Business Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley	officer: Chief Administrative Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723